Emmbi Industries (EMMPOL)

Similar documents
D-Link India (DLILIM) 105

Wabco India (WABTVS) Having a safe and brake free ride! Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Cement. Pet coke ban to dent margins in short-term. Sector Update. ICICI Securities Ltd Retail Equity Research. November 20, 2017

Bodal Chemicals (BODCHE)

Schaeffler India (FAGBEA) 4800

Mayur Uniquoters (MAYUNI)

I Direct. nstinct. July 10, 2017

PC Jeweller (PCJEW) 417 Stepping up store expansion via small store s. Management Meet Note. ICICI Securities Ltd Retail Equity Research

Bajaj Finserv (BAFINS) 4375

Bajaj Finserv (BAFINS) 5443

Lumax Industries (LUMIND)

I Direct. nstinct. September 19, 2017

Bajaj Finserv (BAFINS) 3130

I Direct. nstinct. January 4, 2018

I Direct. nstinct. February 7, 2018

Graphite Electrodes. Good times to continue... Sector Update. ICICI Securities Ltd Retail Equity Research. January 3, 2018

Monte Carlo Fashions (MONCAR) 580

Bajaj Finance (BAJAF) 5498

I Direct. nstinct. March 27, 2018

IndusInd Bank (INDBA) 1717

Singer India (SININ) Focus on tapping small appliances segment. Management Meet Note. ICICI Securities Ltd Retail Equity Research.

Wim Plast Ltd (WIMPLA) 1320

Reliance Capital (RELCAP) 549

I Direct. nstinct. November 27, 2017

Praj Industries (PRAIN)

Reliance Housing Finance

DCB Bank (DCB) 208. Healthy fundamentals priced in. Company Update. ICICI Securities Ltd Retail Equity Research. June 13, 2017

Saregama India (GRACOM) 315

Power Finance Corporation Floor Price 254

Arbitrage Opportunity in Wipro buyback

Stock Trader - Power Grid

Stock Trader: Budget Beneficiary Stock Larsen & Toubro

Oriental Carbon & Chemicals (ORICAR) 950

Stock Trader: ONGC. Research Analysts.

I Direct. nstinct. November 27, 2017

Varun Beverages (VARBEV) 481

Stock Trader - Canara Bank: Focus on Budget

Stock Trader - Focus on Budget: Power Grid

MPS (MACIN) 740. Uncomplicated. anagement Meet Note. ICICI Securities Ltd Retail Equity Research. December 16, 2014

Reliance Capital (RELCAP)

Bank of Baroda (BANBAR) 156

Star Ferro & Cement (STAFER) 113

KPIT Cummins Infosystems (KPISYS)

State Bank of India (STABAN) 335

Graphite India (CAREVE) 110

Quant Picks. Quant Pick

UltraTech Cement (ULTCEM)

Control Print (CONPRI) 290

Premco Global (PREGLO) 600

April 22, Research Analyst

Bharti Airtel (BHATE) 369

Sovereign Gold Bonds. Better option to invest in gold... Gold Bond. Gold back in limelight. July 15, 2016

Consumer Discretionary Thematic 6.0 : Buy Page Industries

Quant Pick: Punjab National Bank

GE Shipping (GESHIP) Striking valuation. Result Update. Rs 262 WHAT S CHANGED. Valuation. February 8, Rating matrix.

Oil & Gas Thematic. Quant Pick

Quant Pick Buy Axis Bank

Taj GVK Hotels (TAJGVK) 167

Union Bank of India (UNIBAN)

October 4, Quant Pick. Research Analyst

Pitti Laminations (PITLAM) 68

Graphite India (CAREVE) 75

NHPC (NHPC) 30. Capacity addition below estimates. Result Update. ICICI Securities Ltd Retail Equity Research. June 5, 2017

Sovereign Gold Bonds. Attractive option to invest in gold... Gold Bond. Gold back in limelight. February 24, 2017

Pitti Laminations (PITLAM) 64

Stocks with high h short build-up likely l candidates for short covering amid recent FPI guidelines

ITC Ltd. RESULT UPDATE 27th October, 2017

Graphite India (CAREVE) 454

Motherson Sumi (MOTSUM) 323

Gladiator Stocks: Reliance Industries

Simplex Infrastructure (SIMCON)

Phillips Carbon Black (PHICAR) 240

Nestle India Ltd. RESULT UPDATE

Graphite India (CAREVE) 75

Power Grid Corporation (POWGRI) 132

Allahabad Bank (ALLBAN): Down trend line breakout after base formation

Symphony Ltd. RESULT UPDATE 31st October 2017

Graphite India (CAREVE) 82

Gladiator Stocks. Scrip I-Direct Code Action Target Stoploss Upside Tata Power TATPOW Buy in the range of

Pitti Laminations (PITLAM) 60

Pitti Laminations (PITLAM) 33

Biocon (BIOCON) Back on track. Result Update WHAT S CHANGED. ICICI Securities Ltd Retail Equity Research. October 21, 2011

Phillips Carbon Black (PHICAR) 415

Research Analysts

Stocks on the move. Scrip I-Direct Code Action Target Stoploss Upside Bharti Airtel BHAAIR Buy in the range of

Gladiator Stocks: Rallis India

Research Analysts

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Equity Advised Portfolio Service (EAPS) External Circulation Permitted January Monthly Update

Power Grid Corporation (POWGRI) 138

Precision Camshaft. Pricing looks imprecise... IPO Review. Price band ICICI Securities Ltd Retail Equity Research. Key Investment rationale

Mahanagar Gas (MAHGAS) 985

Gladiator Stocks. Research Analysts. May 3, Cummins India CUMIND Buy in the range of

Metals & Mining. Chinese steel production on declining trend. Monthly Update. ICICI Securities Ltd Retail Equity Research.

Colgate-Palmolive India Ltd.

I Direct. nstinct. July 13, 2017

KEC International (KECIN) 245

Siyaram Silk Mills (SIYSIL) 575

Research Analysts. March 18, Larsen & Tourbo LARTOU Buy in the range of

Gladiator Stocks. Federal-Mogul Goetze (India) Ltd. FEDGOE Buy in the range of

Transcription:

Management Meet Note Rating Matrix Rating : Unrated Target : NA Target Period : NA Potential Upside : NA Key Financials Crore Net Sales 2.2 139.7 157.9 182.6 EBITDA 9.8 12.6 15.3 19.7 Net Profit 3.3 3.2 4.3 6.0 EPS ( ) 2.0 1.8 2.4 3.4 Valuation Summary P/E 40.2 43.8 32.9 23.6 EV / EBITDA 19.1 15.9 13.7 11.1 P/BV 2.6 2.6 2.4 2.2 RoNW (%) 6.5 5.9 7.4 9.5 RoCE (%) 8.2 8.6 9.5 11.5 Stock Data Particular Amount Market Capitalization 142 crore Total Debt (FY15) 81 crore Cash and Investments (FY15) 3.3 crore EV 219 crore 52 week H/L 96 / 13 Equity capital 17.7 crore Face value.0 MF Holding (%) 0.0 FII Holding (%) 0.0 Price Performance 1M 3M 6M 12M Emmbi Industries 17.0 145.1 296.5 511.4 Kanpur Plastipack 62.5 63.9 194.9 194.5 Neocorp International (11.9) (15.9) 12.2 (19.7) Flexituff International (15.8) (16.3) (20.8) (.0) Price Movement,000 8,000 6,000 4,000 2,000 Jan13 May13 Research Analysts Oct13 Feb14 Price (R.H.S) Chirag J Shah shah.chirag@icicisecurities.com Jun14 Nov14 Shashank Kanodia shashank.kanodia@icicisecurities.com Mar15 Jul15 Nifty (L.H.S) Dec15 0 80 60 40 20 0 Moving up the value chain... December 23, 2015 We recently met Makrand Appalwar, Chairman & Managing Director of Emmbi Industries (Emmbi), to get an insight into the domestic flexible intermediate bulk container (FIBC) market, the company s role in the entire value chain and innovation drivers at Emmbi. Emmbi is a leading FIBC player domestically with manufacturing capability in FIBCs capable of handling load in the range of 5003500 kg, which are in generalised and specialised category. In the specialised category (advance composites), Emmbi manufactures FIBCs, which are anti corrosive, anti carcinogenic, tamper proof, etc. The company also manufactures polypropylene based water tanks, canal liners and agri products viz. crop covers, shade nets, etc. The current capacity of Emmbi is 18200 metric tonnes. The company operated at 68% utilisation levels in FY15. In FY1215, sales grew at 21.3% CAGR to 183 crore in FY15. PAT grew at 22.3% CAGR in FY1215 to 6 crore in FY15 primarily on the back of 120 bps expansion in EBITDA margin to.8% in FY15. Going forward, on the back of increasing share of valueadded products viz. advance composites and water tanks amid increasing government focus on water conservation, Emmbi is on a strong footing with robust prospects, going forward. New products: Innovating to the core Emmbi is a pioneer in the art of innovation. It has over a period of time launched innovative products suiting the market dynamics. Emmbi was the first to introduce flexible water tanks (patent registered), which was a huge success in the domestic market, particularly Maharashtra. In FY15; sales comprised speciality packaging (FIBCs; 47.8% of sales, 9.5% EBITDA margins), advance composites (FIBCs + functionality; 35.5% of sales, 11% EBITDA margins), water conservation products (tanks, liners, 14.5% of sales, 15% EBITDA margins) and agri products (nets, irrigation systems, 2.3% of sales, 16% EBITDA margins). High working capital, geared balance sheet!!! In FY15, gross sales were at 192 crore, comprising domestic sales ( 90 crore, 47% share) and exports ( 2 crore, 53% share). Thus, by virtue of having a large proportion of export sales, Emmbi has an elongated working capital with net working capital days as of FY15 at 171 days. The company also has a leveraged balance sheet with debt as of FY15 at 81 crore with consequent debt: equity at 1.3x. However, with increasing share of high margin valueadded products (advance composites and water conservation products) and the management s focus on controlling the working capital cycle, the leverage should decline, going forward. This would also lead to an improvement in EBITDA margins with consequent earnings growth over FY1518E. Exhibit 1: Financial Performance Crore FY12 FY13 FY14 FY15 H1FY16 Net Sales 2.2 139.7 157.9 182.6 98.0 EBITDA 9.8 12.6 15.3 19.7 11.8 Net Profit 3.3 3.2 4.3 6.0 4.4 EPS ( ) 2.0 1.8 2.4 3.4 2.5 P/E 40 44 33 24 NA EV / EBITDA 19.1 15.9 13.7 11.1 NA P/BV 2.6 2.6 2.4 2.2 NA RoNW (%) 6.5 5.9 7.4 9.5 NA RoCE (%) 8.2 8.6 9.5 11.5 NA Emmbi Industries (EMMPOL) 85 ICICI Securities Ltd Retail Equity Research

Key financials Revenues have grown at 21.3% CAGR in FY1215 to 182.6 crore in FY15 ( 2.2 crore in FY12). Revenues can be subdivided into domestic (gross sales in FY15 at 90 crore) and exports (gross sales in FY15 at 2 crore). The manufactured goods sales in FY15 came in at 173 crore while traded goods sales in FY15 were at 18 crore. Exhibit 2: Revenue trend; grows at CAGR of 21.3% in FY1215 200 182.6 150 139.7 157.9 0 2.2 50 Exhibit 3: Revenue bifurcation (manufactured, traded & services) 250 200 Export sales have increased at a CAGR of 26.5% in FY1215 to 2 crore in FY15. Domestic sales have grown a tad lower at a CAGR of 18.1% in FY1215 to 90 crore in FY15 150 0 50 89.7 80.2 84.6 54.5 50.4 62.4 86.7 2.0 Exports Domestic Exhibit 4: Revenue bifurcation (product type) Sales can be bifurcated depending on the product type; speciality packaging ( 87 crore, 47% share in FY15 sales), advance composites ( 65 crore, 36% share in FY15 sales), water conservation products ( 27 crore. 15% share in FY15 sales) and agri products ( 4 crore, 25 share in FY15 sales) Water Conservation Products, 26.5, 15% Agri Products, 4.1, 2% Speciality Packaging, 87.2, 47% Advance Composites, 64.8, 36% ICICI Securities Ltd Retail Equity Research Page 2

Exhibit 5: EBITDA & EBITDA margins (EBITDA grows at CAGR of 26.3% in FY1215) 25 20.8 11 11 Operational efficiencies and increasing share of valueadded products is driving the improvement in EBITDA margins. EBITDA margins have improved 120 bps in FY1215 with FY15 EBITDA margins at.8% vs. 9.6% in FY12 15 5 9.8 9.6 12.6 9.0 15.3 9.7 19.7 9 9 % 8 EBITDA (LHS) EBITDA Margin (RHS) Though subdued, the return ratios are seeing an uptick. The RoCE has improved from 8.2% in FY12 to 11.5% in FY15. RoE, on the other hand, has improved from 6.5% in FY12 to 9.5% in FY15. Exhibit 6: RoCE & RoE trend Exhibit 7: PAT grows at CAGR of 22.3% in FY1215 % 14 12 8 6 4 2 11.5 9.5 8.2 8.6 9.5 7.4 6.5 5.9 RoNW (%) RoCE (%) 8 6 4 2 3.4 2.4 2.0 1.8 3.3 3.2 4.3 6.0 Net Profit EPS ( ) 4 3 2 1 /share PAT has grown at a CAGR of 22.3% in FY1215 to 6.0 crore in FY15. EPS in FY15 was at 3.4/share. Exhibit 8: Net working capital days 175 170 167 175 171 Net working capital days are a bit stretched at ~170 days due to the higher proportion of exports in the total sales mix. Exports: domestic sales mix in FY15 was at 53:47 days 165 160 158 155 150 NWC Days ICICI Securities Ltd Retail Equity Research Page 3

Exhibit 9: Product profile Speciality Packaging Advance Composites Water Conservation Products Agri Products ICICI Securities Ltd Retail Equity Research Page 4

Financial summary Profit and loss statement Crore (Yearend March) FY12 FY13 FY14 FY15 Net Sales 2.2 139.7 157.9 182.6 Other Operating Income 0.0 0.5 1.1 1.2 Total Operating Income 2.2 140.2 159.0 183.8 Growth (%) 37.2 13.4 15.6 Raw Material Expenses 70.6 0.1 1.7 130.3 Employee Expenses 6.0 6.1 5.5 6.2 Other Operating Expense 15.9 21.4 27.5 27.6 Total Operating Expenditure 92.4 127.6 143.7 164.1 EBITDA 9.8 12.6 15.3 19.7 Growth (%) 28.8 21.7 28.4 Depreciation 1.7 2.5 2.9 3.1 Interest 3.2 5.3 6.3 8.9 Other Income 0.1 0.0 0.1 0.6 PBT 5.0 4.8 6.2 8.3 Exceptional Item 0.0 0.0 0.0 0.0 Total Tax 1.7 1.6 1.9 2.3 PAT 3.3 3.2 4.3 6.0 Growth (%) 1.5 33.0 39.5 EPS ( ) 2.0 1.8 2.4 3.4 Cash flow statement Crore (Yearend March) FY12 FY13 FY14 FY15 Profit after Tax 3.3 3.2 4.3 6.0 Add: Depreciation 1.7 2.5 2.9 3.1 (Inc)/dec in Current Assets 14.7 16.9 9.6 8.9 Inc/(dec) in CL and Provisions 2.2 3.1 0.6 1.7 Others 3.2 5.3 6.3 8.9 CF from operating activities 4.4 2.8 3.3 7.4 (Inc)/dec in Investments 0.1 0.0 0.0 0.0 (Inc)/dec in Fixed Assets 11.8 6.9 7.3 6.7 Others 0.7 0.6 0.6 0.7 CF from investing activities 11.0 6.3 6.7 6.0 Issue/(Buy back) of Equity 0.0 1.2 0.0 0.0 Inc/(dec) in loan funds 16.5 13.3.0 11.3 Dividend paid & dividend tax 0.6 0.4 0.5 0.6 Inc/(dec) in Share Cap 0.8 0.8 0.0 0.0 Others 3.2 4.6 6.3 9.0 CF from financing activities 13.5 8.7 3.2 1.7 Net Cash flow 2.0 0.4 0.2 3.1 Opening Cash 2.7 0.8 0.4 0.2 Closing Cash 0.8 0.4 0.2 3.3 Balance sheet Crore (Yearend March) FY12 FY13 FY14 FY15 Liabilities Equity Capital 16.5 17.7 17.7 17.7 Reserve and Surplus 33.1 36.7 40.5 45.7 Total Shareholders funds 50.4 54.4 58.2 63.4 Total Debt 46.0 59.3 69.3 80.6 Deferred Tax Liability 3.1 3.7 4.3 5.0 Total Liabilities 99.5 117.4 131.8 149.0 Assets Gross Block 46.1 56.5 63.9 70.0 Less: Acc Depreciation 6.6 9.0 12.0 14.6 Net Block 39.5 47.5 51.9 55.5 Capital WIP 3.6 0.0 0.0 0.0 Total Fixed Assets 43.1 47.5 51.9 55.5 Liquid Investments 0.0 0.0 0.0 0.0 Other Investments 0.3 0.3 0.3 0.3 Inventory 29.4 40.6 48.6 54.7 Debtors 20.4 25.6 31.2 33.4 Loans and Advances 12.2 12.8 8.8 9.2 Other Current Assets 0.0 0.0 0.0 0.0 Cash 0.8 0.4 0.2 3.3 Total Current Assets 62.8 79.3 88.7 0.7 Creditors 3.1 5.7 4.2 2.6 Provisions 3.5 4.0 4.9 4.8 Current Liabilities & Prov 6.6 9.7 9.1 7.4 Net Current Assets 56.2 69.6 79.6 93.3 Application of Funds 99.5 117.4 131.8 149.0 Key ratios (Yearend March) FY12 FY13 FY14 FY15 Per share data ( ) EPS 2.0 1.8 2.4 3.4 Cash EPS 3.0 3.2 4.1 5.1 BV 30.5 30.7 32.9 35.8 DPS 0.4 0.2 0.3 0.4 Cash Per Share (Incl Invst) 0.5 0.2 0.1 1.9 Operating Ratios (%) EBITDA Margin 9.6 9.0 9.6.7 PBT / Total Op. income 4.9 3.4 3.9 4.5 PAT Margin 3.2 2.3 2.7 3.3 Inventory days 5 6 112 9 Debtor days 73 67 72 67 Creditor days 11 15 5 Return Ratios (%) RoE 6.5 5.9 7.4 9.5 RoCE 8.2 8.6 9.5 11.5 RoIC 8.5 8.6 9.5 11.4 Valuation Ratios (x) P/E 40.2 43.8 32.9 23.6 EV / EBITDA 19.1 15.9 13.7 11.1 EV / Net Sales 1.8 1.4 1.3 1.2 Market Cap / Sales 1.4 1.0 0.9 0.8 Price to Book Value 2.6 2.6 2.4 2.2 Solvency Ratios Debt/EBITDA 4.7 4.7 4.5 4.1 Debt / Equity 0.9 1.1 1.2 1.3 Current Ratio 9.4 8.1 9.7 13.2 Quick Ratio 4.9 4.0 4.4 5.8 ICICI Securities Ltd Retail Equity Research Page 5

RATING RATIONALE ICICIdirect.com endeavours to provide objective opinions and recommendations. ICICIdirect.com assigns ratings to its stocks according to their notional target price vs. current market price and then categorises them as Strong Buy, Buy, Hold and Sell. The performance horizon is two years unless specified and the notional target price is defined as the analysts' valuation for a stock. Strong Buy: >15%/20% for large caps/midcaps, respectively, with high conviction; Buy: >%/15% for large caps/midcaps, respectively; Hold: Up to +/%; Sell: % or more; Pankaj Pandey Head Research pankaj.pandey@icicisecurities.com ICICIdirect.com Research Desk, ICICI Securities Limited, 1 st Floor, Akruti Trade Centre, Road No. 7, MIDC, Andheri (East) Mumbai 400 093 research@icicidirect.com ICICI Securities Ltd Retail Equity Research Page 6

Disclaimer ANALYST CERTIFICATION We /I, Chirag Shah PGDBM; Shashank Kanodia MBA (Capital Markets), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: ICICI Securities Limited (ICICI Securities) is a Sebi registered Research Analyst having registration no. INH000000990. ICICI Securities Limited (ICICI Securities) is a fullservice, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of financial products. ICICI Securities is a whollyowned subsidiary of ICICI Bank which is India s largest private sector bank and has its various subsidiaries engaged in businesses of housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. ( associates ), the details in respect of which are available on www.icicibank.com. ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research Department. ICICI Securities generally prohibits its analysts, persons reporting to analysts and their relatives from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Nonrated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances. This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forwardlooking statements are not predictions and may be subject to change without notice. ICICI Securities or its associates might have managed or comanaged public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or comanaging public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction. ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the companies mentioned in the report in the past twelve months. ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts have any material conflict of interest at the time of publication of this report. It is confirmed that Chirag Shah PGDBM; Shashank Kanodia MBA (Capital Markets), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ICICI Securities or its subsidiaries collectively or Research Analysts do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report. Since associates of ICICI Securities are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. It is confirmed that Chirag Shah PGDBM; Shashank Kanodia MBA (Capital Markets), Research Analysts do not serve as an officer, director or employee of the companies mentioned in the report. ICICI Securities may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither the Research Analysts nor ICICI Securities have been engaged in market making activity for the companies mentioned in the report. We submit that no material disciplinary action has been taken on ICICI Securities by any Regulatory Authority impacting Equity Research Analysis activities. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ICICI Securities and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. ICICI Securities Ltd Retail Equity Research Page 7